```html

Ovulitis (Pelvic Inflammatory Disease)

Overview

Ovulitis is an older term that historically referred to inflammation of the ovaries, but in modern medicine it is generally considered part of pelvic inflammatory disease (PID). PID is an infection and inflammation of the female upper genital tract—including the uterus, fallopian tubes, ovaries, and surrounding pelvic tissue.

• Who it affects: Women of reproductive age (15‑44 years) are most commonly affected, though PID can occur after menopause if a genital tract infection spreads.
• Prevalence: In the United States, the CDC estimates ~1 million new cases of PID each year, translating to roughly 0.2 % of women annually. Worldwide, the burden is higher in low‑resource settings where untreated sexually transmitted infections (STIs) are common (WHO, 2022).
• Why it matters: Untreated PID can cause chronic pelvic pain, infertility, ectopic pregnancy, and life‑threatening emergencies such as tubo‑ovarian abscesses.

Symptoms

Symptoms can range from mild to severe and may develop gradually over several days or weeks. Not all women experience every symptom.

• Lower abdominal or pelvic pain: Often described as a dull, constant ache that worsens with movement or intercourse.
• Abnormal vaginal discharge: Thick, yellow‑green, foul‑smelling, and may be accompanied by itching.
• Fever & chills: Low‑grade (≤38 °C) is common; high fever may signal a complication.
• Irregular menstrual bleeding: Spotting between periods or heavier menstrual flow.
• Dyspareunia: Painful sexual intercourse.
• dysuria or urinary urgency: Often mistaken for a urinary tract infection.
• Nausea or vomiting: May accompany severe abdominal pain.
• General malaise: Feeling “run down” or fatigued.

In up to 30 % of cases, especially in adolescents, the first sign may be an acute abdomen that requires urgent medical evaluation.

Causes and Risk Factors

Primary infectious agents

• Sexually transmitted bacteria: Chlamydia trachomatis (most common) and Neisseria gonorrhoeae.
• Other bacteria: Mycoplasma genitalium, anaerobes (e.g., Bacteroides), and genital mycoplasmas.
• Post‑procedural infections: After intrauterine device (IUD) insertion, endometrial biopsy, or abortion.
• Non‑STI causes (rare): Tuberculosis, pelvic actinomycosis, or appendicitis that spreads to the pelvis.

Risk factors

• Multiple or new sexual partners.
• Inconsistent condom use.
• History of an STI or prior PID.
• Age < 25 years (cervical ectopy makes infection easier).
• Douching or use of intra‑vaginal chemicals.
• Intrauterine device (IUD) insertion within the past 6 weeks (risk is low but present).
• Pregnancy or postpartum period (immune changes increase susceptibility).
• Immunocompromised state (e.g., HIV infection).

Diagnosis

Diagnosing PID is primarily clinical, supported by laboratory and imaging studies.

Clinical criteria (CDC 2021)

PID should be considered in any woman with ≥2 of the following:

1. Lower abdominal tenderness.
2. Cervical motion tenderness (pain on moving the cervix during speculum exam).
3. Adnexal tenderness (pain over the ovaries/fallopian tubes).

If only one of the above is present, additional findings such as fever >38 °C, abnormal discharge, or laboratory evidence of STI increase the likelihood.

Laboratory tests

• STI screening: Nucleic acid amplification tests (NAAT) for C. trachomatis and N. gonorrhoeae from urine or vaginal swab.
• Complete blood count (CBC): May reveal leukocytosis.
• C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR): Inflammatory markers that rise with infection.
• Pregnancy test: Essential to rule out ectopic pregnancy.

Imaging

• Transvaginal ultrasound: First‑line; can identify tubo‑ovarian abscess, hydrosalpinx, or free fluid.
• CT or MRI: Reserved for atypical presentations or when an abscess is suspected.

Laparoscopy (diagnostic)

Considered the gold standard for confirming PID and assessing its severity, but is invasive and used only when the diagnosis is uncertain or surgical intervention is needed.

Treatment Options

Early treatment reduces the risk of long‑term sequelae. Management includes antibiotics, possible procedures, and supportive care.

Antibiotic regimens (CDC 2021 recommendations)

Regimen	Components	Duration
Outpatient, single‑dose	Ceftriaxone 250 mg IM + Doxycycline 100 mg PO BID for 14 days ± Metronidazole 500 mg PO BID for 14 days	14 days
Outpatient, multidose	Ceftriaxone 250 mg IM single dose, then Doxycycline 100 mg PO BID for 14 days ± Metronidazole 500 mg PO BID for 14 days	14 days
Inpatient (severe)	IV Cefoxitin 2 g q8h + Doxycycline 100 mg PO/IV BID OR IV Clindamycin 900 mg q8h + Gentamicin 5 mg/kg q24h	24‑48 h IV then switch to oral for total 14 days

Metronidazole covers anaerobic bacteria and is recommended when a tubo‑ovarian abscess or bacterial vaginosis is suspected.

Surgical interventions

• Laparoscopic drainage: Preferred for tubo‑ovarian abscesses > 7 cm or when there is no response to antibiotics after 48–72 h.
• Salpingectomy or hysterectomy: Rare, reserved for uncontrollable infection or life‑threatening hemorrhage.
• Removal of an IUD: Should be done promptly if the device was inserted within the past 6 weeks and PID is suspected.

Supportive care

• Pain control with acetaminophen or NSAIDs (e.g., ibuprofen).
• Hydration and rest.
• Partner notification and treatment to prevent reinfection.

Living with Ovulitis (Pelvic Inflammatory Disease)

While most women recover fully with appropriate therapy, many experience ongoing symptoms or lifestyle adjustments.

Daily management tips

• Adhere to the full antibiotic course: Even if symptoms improve after a few days.
• Follow‑up appointments: Usually within 72 hours of starting treatment to ensure resolution.
• Track pain & bleeding: Keep a simple diary; report worsening or new pain promptly.
• Gentle activity: Light walking is encouraged; avoid heavy lifting or vigorous exercise until pain subsides.
• Pelvic floor exercises: Can help reduce chronic pelvic pain after PID.
• Sexual activity: Abstain until treatment is completed and symptoms have resolved (typically 7 days after antibiotics start).
• Contraception counseling: Discuss options that do not increase infection risk (e.g., condoms, hormonal methods without IUD if recent infection).

Emotional health

PID can cause anxiety about fertility and future pregnancies. Consider counseling, support groups, or fertility specialists if concerns arise.

Prevention

• Consistent condom use: Reduces STI transmission by up to 80 % (CDC, 2022).
• Routine STI screening: At least annually for sexually active women < 25 years, and after any new partner.
• Prompt treatment of STIs: Partner treatment prevents reinfection.
• Avoid douching: It disrupts normal vaginal flora and increases infection risk.
• Safe IUD insertion: Performed by experienced clinicians with prophylactic antibiotics if indicated.
• Vaccination: HPV vaccine lowers the incidence of cervical infections that can co‑exist with PID.

Complications

If PID is not treated promptly, several serious outcomes may occur.

• Infertility: Damage or scarring of the fallopian tubes occurs in 10‑20 % of women with severe PID (Mayo Clinic, 2023).
• Ectopic pregnancy: Risk rises 4‑12 % due to tubal obstruction.
• Chronic pelvic pain: Affects up to 30 % of survivors, often requiring multidisciplinary pain management.
• Tubo‑ovarian abscess (TOA): A collection of pus that may rupture, causing peritonitis.
• Peritonitis & sepsis: Life‑threatening systemic infection.
• Adhesions: Internal scar tissue that can cause bowel obstruction.

When to Seek Emergency Care

---

Sources: Centers for Disease Control and Prevention (CDC) 2021 & 2022 guidelines; World Health Organization (WHO) “Sexually Transmitted Infections” fact sheets 2022; Mayo Clinic. “Pelvic Inflammatory Disease.” 2023; Cleveland Clinic. “PID: Diagnosis and Treatment.” 2022; National Institutes of Health (NIH) articles on infertility and ectopic pregnancy, 2023.

```